|
Market Closed -
Swiss Exchange
11:31:48 2026-09-04 am EDT
|
5-day change | 1st Jan Change | ||
| 129.58 CHF | -1.33% |
|
+4.72% | +18.23% |
| 06:37pm | Novartis Pelacarsen Fails Phase III Cardiovascular Outcomes Trial | MT |
| Sep. 04 | Novartis Says Pelacarsen Heart Disease Drug Missed Primary Endpoint -- 2nd Update | DJ |
| Market Cap | 304B 262B 246B 225B 421B 28,723B 422B 2,910B 1,129B 14,737B 1,142B 1,117B 47,475B | P/E 2026 * |
22.7x | P/E 2027 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 337B 290B 273B 249B 466B 31,824B 468B 3,225B 1,251B 16,328B 1,266B 1,238B 52,600B | EV / Sales 2026 * |
5.84x | EV / Sales 2027 * | 5.41x |
| Free-Float |
91.66% | Yield 2026 * |
2.7% | Yield 2027 * | 2.81% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
London S.E.
| 0QLR | Delayed | |
|
Xetra
| NOT | Delayed | |
|
Tradegate
| NOT | Real-time | |
|
OTC Markets
| NVSEF | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Wiener Boerse
| NOVN | End-of-day quote | |
|
CBOE
| 0QLR | Real-time |
Last Transcript : Novartis AG
| 1 day | -1.33% | ||
| 1 week | +4.72% | ||
| Current month | +5.13% | ||
| 1 month | +4.00% | ||
| 3 months | +11.86% | ||
| 6 months | +1.49% | ||
| Current year | +18.23% |
| 1 week | 122.64 |  | 132.68 |
| 1 month | 121.02 | | 132.68 |
| Current year | 107.68 | | 132.68 |
| 1 year | 96.03 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Sell | -5,200 | 0.0003% | |||
| 5/4/26 | Sell | 6,800 | 0.0003% | |||
| 2/17/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | |
| -1.25% | +1.75% | +15.93% | -20.49% | 162B | |
| Average | -0.83% | +1.16% | +27.06% | +43.97% | 384.05B | |
| Weighted average by Cap. | -1.03% | +0.60% | +35.75% | +62.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.68B 49.63B 46.7B 42.66B 79.8B 5,446B 80.02B 552B 214B 2,794B 217B 212B 9,001B | 61.38B 52.82B 49.69B 45.4B 84.92B 5,795B 85.15B 587B 228B 2,973B 230B 225B 9,579B |
| Net income | 13.96B 12.01B 11.3B 10.32B 19.31B 1,318B 19.37B 134B 51.82B 676B 52.42B 51.28B 2,178B | 15.53B 13.37B 12.57B 11.49B 21.49B 1,466B 21.55B 149B 57.66B 752B 58.32B 57.05B 2,424B |
| Net Debt | 32.84B 28.26B 26.59B 24.29B 45.44B 3,101B 45.56B 314B 122B 1,591B 123B 121B 5,126B | 27.9B 24.01B 22.59B 20.64B 38.6B 2,634B 38.71B 267B 104B 1,352B 105B 102B 4,354B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | CHF 129.58 | -1.33% | 2,616,060 |
| 26-09-03 | CHF 131.32 | 0.00% | 3,248,432 |
| 26-09-02 | CHF 131.32 | +0.27% | 3,637,896 |
| 26-09-01 | CHF 130.96 | +6.25% | 4,912,644 |
| 26-08-31 | CHF 123.26 | -0.39% | 2,544,960 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
